Imaging Agents

Imaging Agents

Global Imaging Agents Market to Reach $13.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Imaging Agents estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$13.7 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$7.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the X-Ray / CT segment is readjusted to a revised 4.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 9.8% CAGR

The Imaging Agents market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

MRI Segment to Record 3.9% CAGR

In the global MRI segment, USA, Canada, Japan, China and Europe will drive the 3.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$891.2 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2027, while Latin America will expand at a 4.1% CAGR through the analysis period.

Select Competitors (Total 23 Featured) -

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA


Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Imaging Agents: Providing Brighter and Clearer Images for Effective Clinical Diagnosis
Recent Market Activity
Major Growth Drivers in a Nutshell
Growing Need for Early Disease Diagnosis Fosters Demand for Imaging Agents
Select Market Growth Restraints
Contrast Media: Giving Way to Contemporary Offshoots
X-ray/CT Segment Continues to Lead Contrast Media Market
Developed Economies Face Threat from Rising Demand for Contrast Agents in Asia-Pacific
Diagnostic Radiopharmaceuticals to Outdo Contrast Media
Nuclear Medicine: A Potential Growth Avenue for Dx Radiopharmaceuticals
Select PET and SPECT Radioisotopes Used in Nuclear Medicine
Select Cardiology and Oncology Radiopharmaceuticals
Developed Markets Rule the Imaging Agents Market, Developing Regions to Spearhead Future Growth
Imaging Agents – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Aytu BioScience, Inc. (USA)
Bayer Healthcare Pharmaceuticals (Germany)
Bracco Diagnostics, Inc. (USA)
Curium (France)
Daiichi Sankyo Company Limited (Japan)
Bracco-Eisai Co., Ltd (Japan)
Eli Lilly and Company (USA)
GE Healthcare (UK)
Guerbet Group (France)
Lantheus Medical Imaging, Inc. (USA)
Piramal Imaging SA (Switzerland)
3. MARKET TRENDS & DRIVERS
Sustained Expansion of Molecular Imaging Platform Presents Positive Outlook
Novel Radiopharmaceuticals Add New Dimensions to Molecular Imaging
Latest Radiopharmaceuticals to Benefit Molecular Imaging
Microbubbles/Ultrasound Contrast Agents Set for Strong Growth
Growing Interest in Image Guided Surgery Offers New Opportunities
Role of Near-Infrared Contrast Agents for Image Guided Surgery
Fluorescence Optical Imaging - Opens New Avenues
Coronary CT Angiography Opens Up Opportunities for Contrast Agents
List of Iodine-Containing Contrast Agents for Coronary CT Angiography
Targeted Imaging - A Game Changer in the Making
Rising Clinical Acceptance of MRI Systems Augurs Well for Contrast Agents Market
Researchers Develop Iron Oxide-based Contrast Agent for MRI
Nanomaterials Taking the Center Stage
New Nanoparticle Contrast Agents on the Horizon Show Promise
Gadolinium Coated Nanoparticles - A Promising Imaging Agent
Growing Focus on Development of Gold Nanoparticles in X-Ray Imaging
Imaging Agents Make a Welcome Impact in the Field of Alzheimer’s Disease
List of FDA Approved Alzheimer's Diagnostic Imaging Agents
Contrast-Enhanced Tomosynthesis Expands Opportunities
Hyperpolarized Gases as Contrast Agents
Multi-Modal Imaging: Combating Contrast Medium Inconsistencies
Falling Prices Turn on the Heat
Ultrasound Contrast Agents in Diagnosis of Kidney Ailments
PET: A Prime Growth Driver for Diagnostic Radiopharmaceuticals
Innovative Radiotracers to Boost Cardiac Applications for SPECT and PET Modalities
A Peek at Global CVD Stats
Echocardiography Examinations - Improving Diagnostic Quality through Contrast Agents
Opportunities on Rise for Fluorine-Based Myocardial Perfusion Agents
Unfounded Fears of Radiation Exposure: A Major Concern for Nuclear Diagnostics
Rising Incidence of Cancer - A Major Growth Driver
World Cancer Statistics - Incidence and Mortality Data
Improving Healthcare Expenditure to Foster Growth
Aging Population - A Vital Demography
A Peek into Pricing Dynamics
Packaging of Contrast Agents - An Overview
Global Supply Shortages Restrains Radiopharmaceuticals Market
Price Sensitivity & Competition from Alternatives
Lack of Dosage Standards for Pediatric Patients Limits Radiopharmaceutical Efficacy
Reimbursement Scenario
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for X-Ray / CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
TABLE 16: World Imaging Agents Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 17: USA Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 18: USA Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 19: USA 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
CANADA
TABLE 20: Canada Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 21: Canada Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 22: Canada 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
JAPAN
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 23: Japan Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 24: Japan Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 25: Japan 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
CHINA
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 26: China Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 27: China Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 28: China 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
EUROPE
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 29: Europe Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 30: Europe Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 31: Europe 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 32: Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 33: Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 34: Europe 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
FRANCE
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 35: France Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 36: France Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 37: France 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
GERMANY
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 38: Germany Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 39: Germany Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 40: Germany 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
ITALY
TABLE 41: Italy Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 42: Italy Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 43: Italy 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
UNITED KINGDOM
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 44: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 45: UK Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 46: UK 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
SPAIN
TABLE 47: Spain Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 48: Spain Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 49: Spain 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
RUSSIA
TABLE 50: Russia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 51: Russia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 52: Russia 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 54: Rest of Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 55: Rest of Europe 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 57: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 58: Asia-Pacific 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 60: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 61: Asia-Pacific 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
AUSTRALIA
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
TABLE 62: Australia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 63: Australia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 64: Australia 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
INDIA
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
TABLE 65: India Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 66: India Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 67: India 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
SOUTH KOREA
TABLE 68: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 69: South Korea Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 70: South Korea 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 72: Rest of Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
LATIN AMERICA
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
TABLE 74: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 75: Latin America Historic Review for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 76: Latin America 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
TABLE 77: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 78: Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 79: Latin America 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
ARGENTINA
TABLE 80: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 81: Argentina Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 82: Argentina 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
BRAZIL
TABLE 83: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 84: Brazil Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 85: Brazil 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
MEXICO
TABLE 86: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 87: Mexico Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 88: Mexico 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 90: Rest of Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 91: Rest of Latin America 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
MIDDLE EAST
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
TABLE 92: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 93: Middle East Historic Review for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 94: Middle East 15-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
TABLE 95: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 96: Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 97: Middle East 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
IRAN
TABLE 98: Iran Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 99: Iran Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 100: Iran 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
ISRAEL
TABLE 101: Israel Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 102: Israel Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 103: Israel 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
SAUDI ARABIA
TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 105: Saudi Arabia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 106: Saudi Arabia 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
TABLE 107: UAE Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 108: UAE Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 109: UAE 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 111: Rest of Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 112: Rest of Middle East 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
AFRICA
Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
TABLE 113: Africa Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 114: Africa Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 115: Africa 15-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings